- Drugs used in colorectal cancer
1962 5-FU (Fluorouracil Injection) - no restrictions
1998 Xeloda (Capecitabine) - no restrictions
2000 Camptosar (Irinotecan Hydrochloride) - no restrictions
2004 Avastin (Bevacizumab) - mCRC 1st line+
2004 Eloxatin (Oxaliplatin) - no restrictions
2004 Erbitux (Cetuximab) - mCRC 1st line+, KRAS wild type only
2006 Vectibix (Panitumumab) - mCRC 1st line+, KRAS wild type only
2012 Keytruda (Pembrolizumab) - mCRC 1st line, MSI-H only
2012 Zaltrap (Ziv-Aflibercept) - mCRC 2nd line,
2012 Stivarga (Regorafenib) - no restrictions
2014 Cyramza (Ramucirumab) - mCRC 2nd line
2015 Lonsurf (Trifluridine and Tipiracil Hydrochloride) - no restrictions
2017 Opdivo (Nivolumab) - mCRC 1st line+, MSI-H only
2018 Yervoy (Ipilimumab) - mCRC 1st line+, MSI-H only
2019 Zirabev (Bevacizumab.alt) - mCRC 1st line+
2020 Braftovi (Encorafenib) - mCRC, BRAF V600E only
Drug Combinations Used in Rectal Cancer
FOLFIRI
FOLFOXIRI
FOLFOXIRI+AVASTIN
FOLFIRI+AVASTIN
FOLFIRI+ERBITUX
FOLFIRI+VECTIBIX
FOLFOX
FOLFOX+AVASTIN
5FU+LV
XELIRI
XELOX(CAPEOX)
FDA-Approved Colorectal Cancer Treatments (2020)
https://www.empr.com/wp-content/uploads/sites/7/2020/08/FDA-Approved-Colorectal-Cancer-Treatments-0820.pdf